Skip to main content
Premium Trial:

Request an Annual Quote

Parliament Pores Over Peer Review

The UK Parliament's Commons Select Committee announces the launch of its "inquiry into peer review," in which it aims to assess the "effectiveness of the … process used to examine and validate scientific results and papers prior to publication." As part of its investigation, the committee is encouraging public input on all aspects of the peer-review process, including submissions that highlight "the strengths and weaknesses of peer review as a quality control mechanism for scientists, publishers and the public," and possible alternatives to strengthen the system. The submission deadline is March 10. Blogger Frank at Trading Knowledge says that while many people seems to "worry that attempting a change will wreak havoc on the whole academic enterprise and research careers [and] damage the commercial concerns of journal publishers," it's not yet apparent whether there are any systemic problems with peer review, and if there are, whether a "workable alternative" to the system exists. "I hope the Select Committee inquiry will help to move us closer to finding answers to those questions," he says.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.